<DOC>
	<DOCNO>NCT01165216</DOCNO>
	<brief_summary>The primary purpose study establish recommend dose ipilimumab administer combination paclitaxel carboplatin Japanese patient nonsmall-cell lung cancer .</brief_summary>
	<brief_title>Japanese Study Ipilimumab Administered Combination With Paclitaxel/Carboplatin Patients With Nonsmall-cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>Key Histologically cytologically document nonsmallcell lung cancer ( NSCLC ) present stage IIIB disease without indication definitive radiotherapy , stage IV disease , recurrent disease follow radiation therapy surgical resection No prior chemotherapy , hormonal therapy , immunotherapy , targetedtherapy—containing regimen treatment NSCLC Life expectancy least 3 month Eastern Cooperative Oncology Group performance score 01 Adequate bone marrow function Hemoglobin ≥9.0 g/dL Absolute neutrophil count ≥1,500/mm^3 Platelet count ≥100,000/mm^3 Adequate liver function Total bilirubin level ≤2.0*the upper limit normal ( ULN ) Asparate aminotransferase level ≤2.5*ULN Alanine aminotransferase level ≤2.5*ULN Adequate renal function Calculated creatinine clearance base Cockcroft Gault formula ≥50 mL/min . Key Symptomatic central nervous system ( CNS ) metastasis active CNS metastasis require medication Malignant body cavity fluid ( eg , pleural effusion , cardiac effusion , ascites ) recur despite appropriate supportive care Prior radiation ≥30 % major bonemarrow contain area ( pelvis , lumbar spine ) Documented history severe autoimmune immunemediated symptomatic disease require prolonged ( longer 2 month ) systemic immunosuppressant treatment Documented history motor neuropathy consider autoimmune origin ( eg , Guillain Barré syndrome ) Any concurrent malignancy nonmelanoma skin cancer , carcinoma situ cervix , carcinoma situ breast , carcinoma mucous membrane gastrointestinal tract , superficial bladder cancer treat systemic therapy ≥Grade 2 diarrhea History concurrent disease gastrointestinal tract perforation ≥Grade 2 peripheral neuropathy ( motor sensory ) Uncontrolled intercurrent illness include infection require systemic therapy , symptomatic congestive heart failure , uncontrolled hypertension , uncontrolled angina pectoris , uncontrolled peptic ulcer , cardiac arrhythmia require medication Positive finding human immunodeficiency virus antibody , hepatitis B surface antigen , hepatitis C virus antibody .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>